APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Estriol

Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.

Selected research

Market Outlook & Growth Opportunities

Global Estriol Market Outlook and Growth Opportunities 2026

Report ID 173989780427 December 2025195 pages

Choose your research edition.

Industry ResearchEstriol Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Estriol Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Estriol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estriol Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Estriol Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.

The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.

This report provides an overview of the global Estriol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Estriol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Estriol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Estriol market size, projected growth trends, production technologies, key applications, and end-use industries.

Estriol Segment by Company

Jiangxi Yuneng Pharmaceutical

Shanghai Lianlu Industry

Jiangsu Yuanda SYM Pharmaceutical

Estriol Segment by Type

Purity: <99%

Purity: ≥99%

Estriol Segment by Application

Pharmaceutical

Biological Research

Estriol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Estriol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Estriol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Estriol significant trends, drivers, influence factors in global and regions.

6. To analyze Estriol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estriol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estriol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estriol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Estriol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Estriol industry.

Chapter 3: Detailed analysis of Estriol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Estriol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Estriol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Estriol Industry Trends Table 2. Estriol Industry Drivers Table 3. Estriol Industry Opportunities and Challenges Table 4. Estriol Industry Restraints Table 5. Global Estriol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Estriol Revenue Share by Company (2021-2026) Table 7. Global Estriol Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Estriol Sales Volume Share by Company (2021-2026) Table 9. Global Estriol Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Estriol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Estriol Key Company Manufacturing Base & Headquarters Table 12. Global Estriol Company, Product Type & Application Table 13. Global Estriol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Estriol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity: <99% Table 18. Significant Companies of Purity: ≥99% Table 19. Global Estriol Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Estriol Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Estriol Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Estriol Sales Volume Share by Type (2021-2026) Table 23. Global Estriol Sales Volume Share by Type (2027-2032) Table 24. Global Estriol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Estriol Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Estriol Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Estriol Sales Value Share by Type (2021-2026) Table 28. Global Estriol Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical Table 30. Significant Companies of Biological Research Table 31. Global Estriol Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Estriol Sales Volume by Application (2021-2026) & (Kg) Table 33. Global Estriol Sales Volume by Application (2027-2032) & (Kg) Table 34. Global Estriol Sales Volume Share by Application (2021-2026) Table 35. Global Estriol Sales Volume Share by Application (2027-2032) Table 36. Global Estriol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Estriol Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Estriol Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Estriol Sales Value Share by Application (2021-2026) Table 40. Global Estriol Sales Value Share by Application (2027-2032) Table 41. Global Estriol Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Estriol Sales by Region (2021-2026) & (Kg) Table 43. Global Estriol Sales Market Share by Region (2021-2026) Table 44. Global Estriol Sales by Region (2027-2032) & (Kg) Table 45. Global Estriol Sales Market Share by Region (2027-2032) Table 46. Global Estriol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Estriol Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Estriol Sales Value Share by Region (2021-2026) Table 49. Global Estriol Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Estriol Sales Value Share by Region (2027-2032) Table 51. Global Estriol Market Average Price (US$/Kg) by Region (2021-2026) Table 52. Global Estriol Market Average Price (US$/Kg) by Region (2027-2032) Table 53. Global Estriol Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Global Estriol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Estriol Sales by Country (2021-2026) & (Kg) Table 56. Global Estriol Sales Market Share by Country (2021-2026) Table 57. Global Estriol Sales by Country (2027-2032) & (Kg) Table 58. Global Estriol Sales Market Share by Country (2027-2032) Table 59. Global Estriol Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Estriol Sales Value Market Share by Country (2021-2026) Table 61. Global Estriol Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Estriol Sales Value Market Share by Country (2027-2032) Table 63. Jiangxi Yuneng Pharmaceutical Company Information Table 64. Jiangxi Yuneng Pharmaceutical Business Overview Table 65. Jiangxi Yuneng Pharmaceutical Estriol Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Jiangxi Yuneng Pharmaceutical Estriol Product Portfolio Table 67. Jiangxi Yuneng Pharmaceutical Recent Development Table 68. Shanghai Lianlu Industry Company Information Table 69. Shanghai Lianlu Industry Business Overview Table 70. Shanghai Lianlu Industry Estriol Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Shanghai Lianlu Industry Estriol Product Portfolio Table 72. Shanghai Lianlu Industry Recent Development Table 73. Jiangsu Yuanda SYM Pharmaceutical Company Information Table 74. Jiangsu Yuanda SYM Pharmaceutical Business Overview Table 75. Jiangsu Yuanda SYM Pharmaceutical Estriol Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Jiangsu Yuanda SYM Pharmaceutical Estriol Product Portfolio Table 77. Jiangsu Yuanda SYM Pharmaceutical Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Estriol Distributors List Table 81. Estriol Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Estriol Product Image Figure 2. Global Estriol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estriol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Estriol Sales (2021-2032) & (Kg) Figure 5. Global Estriol Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Estriol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity: <99% Image Figure 10. Purity: ≥99% Image Figure 11. Global Estriol Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Estriol Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Estriol Sales Volume Share by Type (2021-2032) Figure 14. Global Estriol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Estriol Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Estriol Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Biological Research Image Figure 19. Global Estriol Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Estriol Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Estriol Sales Volume Share by Application (2021-2032) Figure 22. Global Estriol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Estriol Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Estriol Sales Value Share by Application (2021-2032) Figure 25. Global Estriol Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 26. Global Estriol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Estriol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Estriol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Estriol Sales Value (2021-2032) & (US$ Million) Figure 30. North America Estriol Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Estriol Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Estriol Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Estriol Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Estriol Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Estriol Sales Value (2021-2032) & (US$ Million) Figure 36. South America Estriol Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Estriol Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Estriol Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Estriol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Estriol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Estriol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Estriol Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Estriol Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity: <99%
  • Purity: ≥99%
Applications
  • Pharmaceutical
  • Biological Research
Companies covered
  • Jiangxi Yuneng Pharmaceutical
  • Shanghai Lianlu Industry
  • Jiangsu Yuanda SYM Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Estriol Sales Value (2021-2032)
  4. 1.2.2 Global Estriol Sales Volume (2021-2032)
  5. 1.2.3 Global Estriol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Estriol Market Dynamics
  1. 2.1 Estriol Industry Trends
  2. 2.2 Estriol Industry Drivers
  3. 2.3 Estriol Industry Opportunities and Challenges
  4. 2.4 Estriol Industry Restraints
3 Estriol Market by Company
  1. 3.1 Global Estriol Company Revenue Ranking in 2025
  2. 3.2 Global Estriol Revenue by Company (2021-2026)
  3. 3.3 Global Estriol Sales Volume by Company (2021-2026)
  4. 3.4 Global Estriol Average Price by Company (2021-2026)
  5. 3.5 Global Estriol Company Ranking (2024-2026)
  6. 3.6 Global Estriol Company Manufacturing Base and Headquarters
  7. 3.7 Global Estriol Company Product Type and Application
  8. 3.8 Global Estriol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Estriol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Estriol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Estriol Market by Type
  1. 4.1 Estriol Type Introduction
  2. 4.1.1 Purity: <99%
  3. 4.1.2 Purity: ≥99%
  4. 4.2 Global Estriol Sales Volume by Type
  5. 4.2.1 Global Estriol Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Estriol Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Estriol Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Estriol Sales Value by Type
  9. 4.3.1 Global Estriol Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Estriol Sales Value by Type (2021-2032)
  11. 4.3.3 Global Estriol Sales Value Share by Type (2021-2032)
5 Estriol Market by Application
  1. 5.1 Estriol Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Biological Research
  4. 5.2 Global Estriol Sales Volume by Application
  5. 5.2.1 Global Estriol Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Estriol Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Estriol Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Estriol Sales Value by Application
  9. 5.3.1 Global Estriol Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Estriol Sales Value by Application (2021-2032)
  11. 5.3.3 Global Estriol Sales Value Share by Application (2021-2032)
6 Estriol Regional Sales and Value Analysis
  1. 6.1 Global Estriol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Estriol Sales by Region (2021-2032)
  3. 6.2.1 Global Estriol Sales by Region: 2021-2026
  4. 6.2.2 Global Estriol Sales by Region (2027-2032)
  5. 6.3 Global Estriol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Estriol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Estriol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Estriol Sales Value by Region (2027-2032)
  9. 6.5 Global Estriol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Estriol Sales Value (2021-2032)
  12. 6.6.2 North America Estriol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Estriol Sales Value (2021-2032)
  15. 6.7.2 Europe Estriol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Estriol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Estriol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Estriol Sales Value (2021-2032)
  21. 6.9.2 South America Estriol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Estriol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Estriol Sales Value Share by Country, 2025 VS 2032
7 Estriol Country-level Sales and Value Analysis
  1. 7.1 Global Estriol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Estriol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Estriol Sales by Country (2021-2032)
  4. 7.3.1 Global Estriol Sales by Country (2021-2026)
  5. 7.3.2 Global Estriol Sales by Country (2027-2032)
  6. 7.4 Global Estriol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Estriol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Estriol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Estriol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Estriol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Estriol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Estriol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Estriol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Estriol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Estriol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Estriol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Estriol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Estriol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Estriol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Estriol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Estriol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Estriol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Estriol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Estriol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Estriol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Estriol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Estriol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Estriol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Estriol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Estriol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Estriol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Estriol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Estriol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Estriol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Estriol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Estriol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Estriol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Estriol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Estriol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Estriol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Estriol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Estriol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Estriol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Estriol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Estriol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Estriol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Estriol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Estriol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Estriol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Estriol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Estriol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Estriol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Estriol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Estriol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Estriol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Estriol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Estriol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Estriol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Estriol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Estriol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Estriol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Estriol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Estriol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Estriol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Estriol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Estriol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Estriol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Estriol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Estriol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Estriol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Estriol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Estriol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Estriol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Estriol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Estriol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Estriol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Estriol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Estriol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Estriol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Estriol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Estriol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Estriol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Estriol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Estriol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Estriol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Estriol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Estriol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Estriol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Estriol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Estriol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Estriol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Estriol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangxi Yuneng Pharmaceutical
  2. 8.1.1 Jiangxi Yuneng Pharmaceutical Company Information
  3. 8.1.2 Jiangxi Yuneng Pharmaceutical Business Overview
  4. 8.1.3 Jiangxi Yuneng Pharmaceutical Estriol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jiangxi Yuneng Pharmaceutical Estriol Product Portfolio
  6. 8.1.5 Jiangxi Yuneng Pharmaceutical Recent Developments
  7. 8.2 Shanghai Lianlu Industry
  8. 8.2.1 Shanghai Lianlu Industry Company Information
  9. 8.2.2 Shanghai Lianlu Industry Business Overview
  10. 8.2.3 Shanghai Lianlu Industry Estriol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Lianlu Industry Estriol Product Portfolio
  12. 8.2.5 Shanghai Lianlu Industry Recent Developments
  13. 8.3 Jiangsu Yuanda SYM Pharmaceutical
  14. 8.3.1 Jiangsu Yuanda SYM Pharmaceutical Company Information
  15. 8.3.2 Jiangsu Yuanda SYM Pharmaceutical Business Overview
  16. 8.3.3 Jiangsu Yuanda SYM Pharmaceutical Estriol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Yuanda SYM Pharmaceutical Estriol Product Portfolio
  18. 8.3.5 Jiangsu Yuanda SYM Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Estriol Value Chain Analysis
  2. 9.1.1 Estriol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Estriol Sales Mode & Process
  6. 9.2 Estriol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Estriol Distributors
  9. 9.2.3 Estriol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst